Efficacy of Albuterol SPIROMAX® in Patients With Exercise-Induced Bronchoconstriction
- Study Title
- Efficacy of Albuterol SPIROMAXֲ® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)
- Teva Identifier
- ABS-AS-302
- ClinicalTrials.gov Identifier
- NCT01791972
- Study Status
- Completed
- Trial Condition(s)
- Exercise-Induced Bronchoconstriction (EIB)
- Interventions
- Drug: Albuterol Spiromax | Drug: Placebo Spiromax
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 50 Years
- Trial Duration
- 03/01/2013 - 06/01/2013
- Phase
- Phase 3
